{
    "nctId": "NCT02984475",
    "officialTitle": "The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalasemia Major",
    "inclusionCriteria": "* Diagnosed with Beta-Thalassemia Major and receiving regular blood transfusion and on iron chelating therapy.\n* Weight: equal to or over 35 kg.\n* Normal renal function.\n* Must have minimum age of 11 Years\n* Must have maximum age of 18 Years",
    "exclusionCriteria": "* Patients with renal impairment (serum creatinine more than twice the upper limit of normal).\n* Patients with heart failure.\n* Patients with sepsis or active infection.\n* Patients with diabetes mellitus (either primary or secondary to thalassemia).\n* regular consumption of medication with potential hepatotoxicity.\n* regular herbal medicine or antioxidant supplementation.\n* patients with gastrointestinal conditions preventing adsorption of oral medication."
}